Evidence map›Paper›PMID 31208438›Full record

ArticleBMC research notes2019

HIV-1 subtype C Envelope function becomes less sensitive to N-glycosylation deletion during disease progression.

Evelyn Ngwa Lumngwena, Liliwe Shuping, Netanya Bernitz, Zenda Woodman

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Evelyn Ngwa LumngwenaDepartment of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Liliwe ShupingDivision of the National Laboratory Service, National Institute for Communicable Diseases, Johannesburg, South Africa.
Netanya BernitzDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
Zenda WoodmanDepartment of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. zl.woodman@uct.ac.za.ORCID http://orcid.org/0000-0001-9680-3884
University of Cape Town · ZANational Health Laboratory Service · ZAStellenbosch University · ZA

Funding

National Research Foundation TTK20100723000013129Poliomyelitis Research Foundation 13/25
6 · The paper itself

Abstract

objectiveAs part of a larger study to understand how Envelope N-glycosylation influences HIV-1 pathogenesis, we selected a participant infected with a single Subtype C variant and determined whether deletion of specific potential N-glycan sites (PNGs) impacted Envelope function longitudinally.

resultsWe deleted five PNGs previously linked to HIV-1 transmission of two matched Envelope clones representing variants at 5 and 173 weeks post-infection. The transmitted founder (TF) had significantly better pseudovirus entry efficiency than the chronic infection (CI) variant. Deletion of all PNGs significantly reduced TF entry efficiency, binding to dendritic cell-specific intracellular adhesion molecule 3 grabbing non-integrin (DC-SIGN) receptor and trans-infection. However, mutational analysis did not affect the phenotype of the CI Envelope to the same extent. Notably, deletion of the PNGs at N241 and N448 had no effect on CI Envelope function, suggesting that some PNGs might only be important during acute infection. Therefore, vaccines that elicit antibodies against N-glycans important for TF Envelope function could drive the loss of PNGs during immune escape, abrogating viral replication. Conversely, changes in N-glycosylation might have no effect on some variants, reducing vaccine efficacy. This finding highlights the need for further investigation into the role of Envelope N-glycosylation in HIV-1 pathogenesis.

Indexed as

Amino Acid SequenceBinding SitesCell Adhesion MoleculesCell Line, TumorCells, CulturedDC-Specific ICAM-3 Grabbing NonintegrinDendritic CellsDisease Progressionenv Gene Products, Human Immunodeficiency VirusFemaleGlycosylationHEK293 CellsHIV-1HIV InfectionsHumansLectins, C-TypeCell Adhesion MoleculesDC-Specific ICAM-3 Grabbing Nonintegrinenv Gene Products, Human Immunodeficiency VirusLectins, C-TypeReceptors, Cell SurfaceEnvelope functionEnvelope N-glycosylationHIV-1Transmitted founder

Identifiers

PMID31208438
PMCPMC6580609
OpenAlexW2951781367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.